Group 1 - Ningde Times participated in the completion of the Zeyuan Fund, with a total scale of 10.128 billion yuan, increasing by 50.42% from the previous announcement [3] - Zhongjin Gold's controlling shareholder plans to inject four companies into the company to resolve competition issues, including acquiring stakes in Inner Mongolia Jintao and others [4][5] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [6] Group 2 - China Shenhua intends to acquire 7.43% of the National Energy Group Financial Company for 2.929 billion yuan, which is expected to increase its net profit by 97 million yuan [7] - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange [8] - Hualan Shares is establishing a joint venture for Tibetan medicinal baths and plaster products, with a registered capital of 7 million yuan [15] Group 3 - Yunnan Copper plans to acquire 40% of Liangshan Mining through a share issuance, with the stock resuming trading on May 26 [10] - Ruishun Technology's subsidiary plans to establish a joint venture in Malaysia to provide automation solutions [11] - ST Quanwei's stock will be subject to additional risk warnings due to ongoing litigation involving a subsidiary [12] Group 4 - Hengfeng Information's controlling shareholder has terminated the agreement to transfer part of the company's shares, with no impact on control [13] - Huadian Technology's subsidiary has not yet commenced substantial construction on a polyurethane new materials project [14] - ST Yinjian will remove the delisting risk warning and some other risk warnings, changing its stock name [38] Group 5 - China Tonghao won approximately 3.789 billion yuan in contracts in the rail transit market from March to April [39] - Intercontinental Oil and Gas plans to invest about 848 million USD in the Iraq South Basra project [40][41] - Jiaying Pharmaceutical's subsidiary signed a contract for the development of a traditional Chinese medicine innovation project [42] Group 6 - Ruidong Intelligent signed a strategic cooperation agreement with Shunde Vocational and Technical College to enhance collaboration in technology [43] - Jiaojian Co. won a bid for a drainage project worth 225 million yuan [44] - Hengshun Vinegar's controlling shareholder plans to increase its stake in the company by 50 to 100 million yuan [45]

Mergers and Acquisitions - Zhongjin Gold plans to acquire 49.34% stake in Inner Mongolia Jintao and 80% stake in Hebei Dabaiyang Gold Mine, along with 70% stakes in Liaoning Tianli and Liaoning Jinfeng Gold Mining, to resolve industry competition issues [1] - Dike Co. intends to acquire 60% stake in Zhejiang Sote for 696 million yuan, gaining control over the Solamet photovoltaic silver paste business [2] - China Shenhua plans to acquire 7.43% stake in its financial subsidiary for 2.929 billion yuan, changing the ownership structure to 60% for State Energy Investment Group and 40% for China Shenhua [3] Shareholding Changes - New Light Pharmaceutical's major shareholder plans to reduce its stake by up to 3%, equating to a maximum of 4.8 million shares [4] - Xingfa Group's supervisor increased his shareholding by 15,000 shares, amounting to 311,500 yuan, representing 0.0014% of the total shares [5] - Changhua Group's shareholders plan to reduce their holdings by up to 3%, totaling a maximum of 14.1 million shares [6] Risk Matters - ST Quanwei's stock will face additional risk warnings due to a lawsuit involving a guarantee amounting to 10.0126 million yuan, which exceeds 5% of the company's latest audited net assets [7] - Jinhua Co.'s chairman is under investigation for alleged violations related to shareholding disclosure, but this will not affect the company's daily operations [8]

Company Announcements - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate international strategy and enhance overseas financing capabilities [1] - Zhongjin Gold's controlling shareholder plans to inject four companies, including Inner Mongolia Jintao, into the company to resolve competition issues [2] - Hanchuan Intelligent has filed a lawsuit against CATL and its subsidiaries for approximately 60.88 million yuan due to payment defaults [2] - Yunnan Copper intends to acquire a 40% stake in Liangshan Mining, with stock resuming trading on May 26 [3] - China Shenhua plans to acquire a 7.43% stake in China Energy Group Financial Company for 2.929 billion yuan [3] - Dike Co. intends to acquire 60% of Zhejiang Suote for 696 million yuan to control the Solamet photovoltaic silver paste business [4] - Jin Hua Co.'s chairman is under investigation for information disclosure violations, but it will not affect the company's operations [4] Financing and Investments - Heng Rui Pharmaceutical's H-shares will be listed on May 23, 2025, with a total issuance of 225 million shares at a price of 44.05 HKD per share [23] - Ningde Times' investment fund has increased to 10.128 billion yuan, with the company's stake reduced to 6.91% [8] - Intercontinental Oil and Gas expects to invest approximately 848 million USD in the Iraq South Basra project [9] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [10] Project Bids and Contracts - China Communications has won important rail transit projects totaling approximately 3.789 billion yuan [22] - Anhui Construction has received multiple project bids totaling over 2 billion yuan [22] Operational Updates - Zijin Mining's Kamoa-Kakula copper mine has suspended some underground mining operations due to seismic activity, potentially impacting future production [21] - Shaanxi Natural Gas will reduce pipeline transportation prices by 0.0386 yuan per cubic meter, expected to decrease net profit by approximately 222 million yuan in 2025 [20]

证券代码：600080 股票简称：金花股份 编号：临 2025-025 金花企业（集团）股份有限公司 关于公司董事长收到中国证券监督管理委员会陕西监管局 《行政处罚事先告知书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 你涉嫌信息披露违法违规案，已由我局调查完毕，我局依法拟对你作出行政 处罚。现将我局拟对你作出行政处罚所根据的违法事实、理由、依据及你享有的 相关权利予以告知。 金花企业（集团）股份有限公司（以下简称"公司"）于 2024 年 8 月 23 日披露了《关于公司董事长被采取取保候审措施并收到解除取保候审决定书的公 告》，西安市公安局鄠邑分局于 2024 年 4 月 23 日起决定对董事长邢雅江先生取 保候审，2024 年 7 月 26 日，西安市公安局鄠邑分局出具了《解除取保候审决定 书》，因指证邢雅江的证据发生变化，现有证据不能证实邢雅江有涉案嫌疑，根 据《中华人民共和国刑事诉讼法》第七十九条第二款之规定，决定予以解除取保 候审。（具体内容详见公告：临 2024-047 号） 公司董事长邢雅江先 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 金花企业（集团）股份有限公司（以下简称"公司"）董事长邢雅江先生于 2025 年 5 月 23 日收到中国证券监督管理委员会（以下简称"中国证监会"）下 发的《立案告知书》（编号：证监立案字 0092025004 号），因涉嫌金花企业（集 团）股份有限公司持股变动信息披露等违法违规，根据《中华人民共和国证券法》、 《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司董事长邢雅 江先生进行立案。 本次立案仅针对董事长个人，不会对公司日常生产经营活动产生影响，目前， 公司日常经营运作正常。立案调查期间，公司董事长将积极配合中国证监会的调 查工作。公司将持续关注上述事项的进展情况，并严格按照相关法律法规的规定 和监管要求，及时履行信息披露义务。 公司指定信息披露报刊及网站为《上海证券报》、上海证券交易所网站 (www.sse.com.cn)，公司所有信息均以在上述指定媒体刊登的信息为准。敬请广 大投资者理性投资，注意投资风险。 特此公告。 金花企业（集团）股份有限公司董事 ...

智通财经5月23日电，金花股份(600080.SH)公告称，公司董事长邢雅江于2025年5月23日收到中国证券 监督管理委员会下发的《立案告知书》，因涉嫌金花企业（集团）股份有限公司持股变动信息披露等违 法违规，中国证监会决定对邢雅江进行立案。本次立案仅针对董事长个人，不会对公司日常生产经营活 动产生影响，目前公司日常经营运作正常。 金花股份：公司董事长邢雅江因涉嫌持股变动信息披露违法违规被立案 ...

金花股份（600080）公告，公司董事长邢雅江于2025年5月23日收到中国证监会下发的立案告知书，因 涉嫌金花企业(集团)股份有限公司持股变动信息披露等违法违规，中国证监会决定对其进行立案。本次 立案仅针对董事长个人，不会对公司日常生产经营活动产生影响。公司将持续关注上述事项的进展情 况，并及时履行信息披露义务。 ...

Policy Trends - Recent COVID-19 infections show a slight increase in some regions, but the clinical severity has not changed significantly according to a Chinese CDC expert [2] Drug and Device Approvals - Changshan Pharmaceutical's nadroparin calcium injection has received a drug registration certificate from Belarus, used for treating venous thromboembolism and other related conditions [3] - Shanghai Pharmaceuticals announced that its rivaroxaban tablets have received approval from the US FDA, aimed at reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation patients, among other uses [4] Capital Markets - Shanghai Kejun Pharmaceutical Technology Co., Ltd. completed a B+ round financing exceeding 100 million yuan, with funds primarily allocated for the phase III clinical development of its core product CG-0255 in the cardiovascular field [5] Industry Developments - Jingyin Pharmaceutical and CRISPR Therapeutics have formed a strategic partnership to jointly develop and commercialize a long-acting siRNA therapy for thrombotic diseases [6] - Buchang Pharmaceutical's subsidiary signed a commissioned research agreement with Fubicheng Pharmaceutical for the development of MF59 adjuvant [7] - Sanofi and Pfizer entered into a licensing agreement for a bispecific antibody product targeting PD-1 and VEGF, with Pfizer gaining exclusive rights outside mainland China [9] Public Sentiment Alerts - Jinhua Co., Ltd. reported that shareholder Xinyu Jinyu has reduced its holdings by 133,500 shares, representing 0.035765% of the company's total share capital [10] - Fosun Pharma announced the resignation of its Senior Vice President Rong Yang for personal reasons, effective May 16, 2025 [11]

金花企业（集团）股份有限公司 股东减持计划时间届满暨减持股份结果公告 证券代码：600080 证券简称：金花股份 公告编号：2025-024 本次减持计划实施前，股东新余金煜企业管理有限公司（以下简称"新余金 煜"）持有金花企业（集团）股份有限公司（以下简称"公司"）无限售流通股份 ? 减持计划的实施结果情况 告》（公告编号：临 2025-003 号），自 2025 年 2 月 18 日至 2025 年 5 月 17 日期 间，股东新余金煜计划通过集中竞价的方式减持其所持有的公司无限售流通股份 不超过 3,732,700 股（占公司股本总数不超过 1.00%）。 的提示性公告》（公告编号：临 2025-009 号），股东新余金煜于 2025 年 2 月 18 日 通 过 集 中 竞 价 方 式 减 持 公 司 股 份 133,500 股 （ 占 其 所 持 有 公 司 股 份 的 股减少至 18,663,500 股，变动比例将由 5.04%减少至 4.999996%，不再是公司持 股 5%以上股东。 日至 2025 年 5 月 17 日期间，股东新余金煜通过集中竞价的方式累计减持公司股 份 133,500 股 ...

证券代码：600080 证券简称：金花股份 公告编号：2025-024 金花企业（集团）股份有限公司 股东减持计划时间届满暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东的基本情况 本次减持计划实施前，股东新余金煜企业管理有限公司（以下简称"新余金 煜"）持有金花企业（集团）股份有限公司（以下简称"公司"）无限售流通股份 18,797,000 股，占公司股本总数的 5.04%。 上述减持主体无一致行动人。 二、减持计划的实施结果 (一)股东因以下事项披露减持计划实施结果： 披露的减持时间区间届满 减持计划的实施结果情况 2025 年 1 月 18 日，公司披露了《持股 5%以上股东集中竞价减持股份计划公 告》（公告编号：临 2025-003 号），自 2025 年 2 月 18 日至 2025 年 5 月 17 日期 间，股东新余金煜计划通过集中竞价的方式减持其所持有的公司无限售流通股份 不超过 3,732,700 股（占公司股本总数不超过 1.00%）。 2025 年 2 月 ...